April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Modeling an Inherited RPE Disorder With Human Induced Pluripotent Stem Cells
Author Affiliations & Notes
  • D. M. Gamm
    Ophthalmology and Visual Sciences, Waisman Center, Eye Research Institute,
    Univ of Wisconsin, Madison, Wisconsin
  • S. Howden
    Morgridge Institute,
    Univ of Wisconsin, Madison, Wisconsin
  • L. S. Wright
    Waisman Center,
    Univ of Wisconsin, Madison, Wisconsin
  • B. R. Pattnaik
    Pediatrics, Ophthalmology and Visual Sciences,
    Univ of Wisconsin, Madison, Wisconsin
  • A. Verhoeven
    Waisman Center,
    Univ of Wisconsin, Madison, Wisconsin
  • E. E. Capowski
    Waisman Center,
    Univ of Wisconsin, Madison, Wisconsin
  • R. L. Shearer
    Waisman Center,
    Univ of Wisconsin, Madison, Wisconsin
  • J. Thomson
    Morgridge Institute,
    Univ of Wisconsin, Madison, Wisconsin
  • J. S. Meyer
    Waisman Center,
    Univ of Wisconsin, Madison, Wisconsin
  • Footnotes
    Commercial Relationships  D.M. Gamm, None; S. Howden, None; L.S. Wright, None; B.R. Pattnaik, None; A. Verhoeven, None; E.E. Capowski, None; R.L. Shearer, None; J. Thomson, None; J.S. Meyer, None.
  • Footnotes
    Support  FFB Wynn-Gund Research Acceleration Award, Lincy Foundation, RPB McCormick Scholar Award, Walsh Foundation, Retina Research Foundation, Heckrodt Foundation, and NICHD P30 HD03352
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 2490. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      D. M. Gamm, S. Howden, L. S. Wright, B. R. Pattnaik, A. Verhoeven, E. E. Capowski, R. L. Shearer, J. Thomson, J. S. Meyer; Modeling an Inherited RPE Disorder With Human Induced Pluripotent Stem Cells. Invest. Ophthalmol. Vis. Sci. 2010;51(13):2490.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : The ability of human induced pluripotent stem cells (hiPSCs) to generate specific retinal cell types has recently been established. One highly anticipated use of hiPSCs is as a means to model cell autonomous disease processes. In this study, we sought to generate and characterize a hiPSC line derived from a patient with an RPE-based inherited retinal degenerative disease.

Methods: : hiPSCs were differentiated towards a retinal fate using a previously described method. Within 2 months of differentiation, uniform pigmentation was observed in a significant fraction of hiPSC-derived neurospheres. Pigmented neurospheres were manually isolated, plated on laminin and expanded in the presence of FGF2 and EGF. hiPSC-RPE produced in this manner was compared to human embryonic stem (ES)- and fetal-derived RPE using PCR, ICC and functional assays. To demonstrate the potential of hiPSCs to model human disease, iPS cells were derived from a patient with gyrate atrophy, differentiated into RPE and tested for ornithine aminotransferase (OAT) activity.

Results: : hiPSCs were differentiated towards a retinal fate using a previously described method. Within 2 months of differentiation, uniform pigmentation was observed in a significant fraction of hiPSC-derived neurospheres. Pigmented neurospheres were manually isolated, plated on laminin and expanded in the presence of FGF2 and EGF. hiPSC-RPE produced in this manner was compared to human embryonic stem (ES)- and fetal-derived RPE using PCR, ICC and functional assays. To demonstrate the potential of hiPSCs to model human disease, iPS cells were derived from a patient with gyrate atrophy, differentiated into RPE and tested for ornithine aminotransferase (OAT) activity.

Conclusions: : This study confirms that RPE derived from hiPSCs is similar to that derived from human ES and prenatal sources. Furthermore, patient-specific hiPSCs can be used to produce retinal cell types that retain disease-causing functional defects. As such, hiPSCs should prove useful for studying the pathophysiology of some human retinal diseases, as well as for screening small molecules for therapeutic effects.

Keywords: retinal degenerations: hereditary • retinal pigment epithelium • differentiation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×